Nicorette Invisipatch (Nicotine)

The nicotine in the patch is absorbed transdermally and binds to nicotinic acetylcholine receptors in the brain. This partial stimulation eases withdrawal, lessens cravings, and allows the user to gradually lower nicotine exposure, supporting a step‑down approach to quitting smoking.

The appropriate patch strength and duration are determined by the prescribing clinician based on the individual’s smoking habits, previous quit attempts, and health status. The prescriber selects the specific product that matches the patient’s needs.

Safety data for nicotine patches in pregnancy and lactation are limited. Healthcare professionals generally advise against use during pregnancy and breastfeeding unless the potential benefit outweighs the risk, and alternative cessation methods should be considered.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with gum, lozenges or inhalers, the patch offers continuous nicotine delivery over 16–24 hours, which can improve adherence and reduce the frequency of dosing. However, individual response varies, and some users may prefer short‑acting forms for flexible dosing.

Store the patches at room temperature, below 25 °C, in their original sealed pouch. Keep them away from moisture, direct sunlight and heat sources. Do not expose the patches to temperatures above the recommended range, as this may affect nicotine stability.

The patch is applied to clean, dry, hair‑free skin on the upper arm, chest, or back. Press firmly for several seconds to ensure good contact, then replace it according to the prescriber’s schedule, typically every 16–24 hours, rotating sites to avoid skin irritation.

Serious risks include severe hypertension, tachycardia, chest pain, allergic skin reactions, and, rarely, seizures. Users should seek immediate medical attention if they experience any of these symptoms, especially if they have underlying cardiovascular disease.

The patch should not be used by individuals who are not regular smokers, those with uncontrolled hypertension, recent myocardial infarction, severe heart disease, or known hypersensitivity to nicotine or any patch components. Pregnant or breastfeeding women should consult a healthcare professional before use.